nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—Lisinopril—systemic scleroderma	0.16	0.272	CbGbCtD
Ticagrelor—ABCB1—Captopril—systemic scleroderma	0.12	0.203	CbGbCtD
Ticagrelor—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0942	0.16	CbGbCtD
Ticagrelor—ABCB1—Prednisone—systemic scleroderma	0.0753	0.128	CbGbCtD
Ticagrelor—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0564	0.0959	CbGbCtD
Ticagrelor—CYP3A4—Prednisone—systemic scleroderma	0.0451	0.0767	CbGbCtD
Ticagrelor—ABCB1—Methotrexate—systemic scleroderma	0.0378	0.0642	CbGbCtD
Ticagrelor—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000675	0.00164	CcSEcCtD
Ticagrelor—Chest pain—Leflunomide—systemic scleroderma	0.000675	0.00164	CcSEcCtD
Ticagrelor—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.000673	0.00164	CcSEcCtD
Ticagrelor—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000672	0.00163	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000672	0.00163	CcSEcCtD
Ticagrelor—Constipation—Captopril—systemic scleroderma	0.000671	0.00163	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00067	0.00163	CcSEcCtD
Ticagrelor—Skin disorder—Azathioprine—systemic scleroderma	0.000665	0.00162	CcSEcCtD
Ticagrelor—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000664	0.00161	CcSEcCtD
Ticagrelor—Cough—Mycophenolic acid—systemic scleroderma	0.00066	0.0016	CcSEcCtD
Ticagrelor—Back pain—Lisinopril—systemic scleroderma	0.000659	0.0016	CcSEcCtD
Ticagrelor—Vomiting—Pentoxifylline—systemic scleroderma	0.000658	0.0016	CcSEcCtD
Ticagrelor—Rash—Pentoxifylline—systemic scleroderma	0.000653	0.00159	CcSEcCtD
Ticagrelor—Hypertension—Mycophenolic acid—systemic scleroderma	0.000653	0.00159	CcSEcCtD
Ticagrelor—Dermatitis—Pentoxifylline—systemic scleroderma	0.000652	0.00158	CcSEcCtD
Ticagrelor—Headache—Pentoxifylline—systemic scleroderma	0.000649	0.00158	CcSEcCtD
Ticagrelor—Feeling abnormal—Captopril—systemic scleroderma	0.000647	0.00157	CcSEcCtD
Ticagrelor—Chest pain—Mycophenolic acid—systemic scleroderma	0.000644	0.00156	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Captopril—systemic scleroderma	0.000642	0.00156	CcSEcCtD
Ticagrelor—Asthenia—Mometasone—systemic scleroderma	0.000641	0.00156	CcSEcCtD
Ticagrelor—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.00064	0.00156	CcSEcCtD
Ticagrelor—Hypotension—Azathioprine—systemic scleroderma	0.00064	0.00155	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000639	0.00155	CcSEcCtD
Ticagrelor—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000636	0.00155	CcSEcCtD
Ticagrelor—Nervous system disorder—Leflunomide—systemic scleroderma	0.000634	0.00154	CcSEcCtD
Ticagrelor—Pruritus—Mometasone—systemic scleroderma	0.000632	0.00154	CcSEcCtD
Ticagrelor—Skin disorder—Leflunomide—systemic scleroderma	0.000628	0.00153	CcSEcCtD
Ticagrelor—Angioedema—Lisinopril—systemic scleroderma	0.000622	0.00151	CcSEcCtD
Ticagrelor—Confusional state—Mycophenolic acid—systemic scleroderma	0.000622	0.00151	CcSEcCtD
Ticagrelor—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000622	0.00151	CcSEcCtD
Ticagrelor—Abdominal pain—Captopril—systemic scleroderma	0.00062	0.00151	CcSEcCtD
Ticagrelor—Body temperature increased—Captopril—systemic scleroderma	0.00062	0.00151	CcSEcCtD
Ticagrelor—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000618	0.0015	CcSEcCtD
Ticagrelor—Nausea—Pentoxifylline—systemic scleroderma	0.000615	0.00149	CcSEcCtD
Ticagrelor—Vertigo—Lisinopril—systemic scleroderma	0.000612	0.00149	CcSEcCtD
Ticagrelor—Diarrhoea—Mometasone—systemic scleroderma	0.000611	0.00149	CcSEcCtD
Ticagrelor—Syncope—Lisinopril—systemic scleroderma	0.000611	0.00148	CcSEcCtD
Ticagrelor—Renal failure acute—Methotrexate—systemic scleroderma	0.000608	0.00148	CcSEcCtD
Ticagrelor—Shock—Mycophenolic acid—systemic scleroderma	0.000607	0.00147	CcSEcCtD
Ticagrelor—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000605	0.00147	CcSEcCtD
Ticagrelor—Hypotension—Leflunomide—systemic scleroderma	0.000604	0.00147	CcSEcCtD
Ticagrelor—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.0006	0.00146	CcSEcCtD
Ticagrelor—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000599	0.00146	CcSEcCtD
Ticagrelor—Loss of consciousness—Lisinopril—systemic scleroderma	0.000598	0.00145	CcSEcCtD
Ticagrelor—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000597	0.00145	CcSEcCtD
Ticagrelor—Cough—Lisinopril—systemic scleroderma	0.000594	0.00144	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000591	0.00144	CcSEcCtD
Ticagrelor—Paraesthesia—Leflunomide—systemic scleroderma	0.000581	0.00141	CcSEcCtD
Ticagrelor—Chest pain—Lisinopril—systemic scleroderma	0.00058	0.00141	CcSEcCtD
Ticagrelor—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000577	0.0014	CcSEcCtD
Ticagrelor—Dyspnoea—Leflunomide—systemic scleroderma	0.000577	0.0014	CcSEcCtD
Ticagrelor—Hypotension—Mycophenolic acid—systemic scleroderma	0.000576	0.0014	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000576	0.0014	CcSEcCtD
Ticagrelor—Dyspepsia—Leflunomide—systemic scleroderma	0.000569	0.00138	CcSEcCtD
Ticagrelor—Vomiting—Mometasone—systemic scleroderma	0.000568	0.00138	CcSEcCtD
Ticagrelor—Feeling abnormal—Azathioprine—systemic scleroderma	0.000564	0.00137	CcSEcCtD
Ticagrelor—Rash—Mometasone—systemic scleroderma	0.000563	0.00137	CcSEcCtD
Ticagrelor—Asthenia—Captopril—systemic scleroderma	0.000563	0.00137	CcSEcCtD
Ticagrelor—Dermatitis—Mometasone—systemic scleroderma	0.000563	0.00137	CcSEcCtD
Ticagrelor—Confusional state—Lisinopril—systemic scleroderma	0.00056	0.00136	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00056	0.00136	CcSEcCtD
Ticagrelor—Headache—Mometasone—systemic scleroderma	0.00056	0.00136	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000558	0.00136	CcSEcCtD
Ticagrelor—Fatigue—Leflunomide—systemic scleroderma	0.000558	0.00135	CcSEcCtD
Ticagrelor—Pruritus—Captopril—systemic scleroderma	0.000555	0.00135	CcSEcCtD
Ticagrelor—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000554	0.00135	CcSEcCtD
Ticagrelor—Constipation—Leflunomide—systemic scleroderma	0.000553	0.00134	CcSEcCtD
Ticagrelor—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00055	0.00134	CcSEcCtD
Ticagrelor—Shock—Lisinopril—systemic scleroderma	0.000547	0.00133	CcSEcCtD
Ticagrelor—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000545	0.00132	CcSEcCtD
Ticagrelor—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000543	0.00132	CcSEcCtD
Ticagrelor—Abdominal pain—Azathioprine—systemic scleroderma	0.000541	0.00132	CcSEcCtD
Ticagrelor—Body temperature increased—Azathioprine—systemic scleroderma	0.000541	0.00132	CcSEcCtD
Ticagrelor—Skin disorder—Lisinopril—systemic scleroderma	0.00054	0.00131	CcSEcCtD
Ticagrelor—Diarrhoea—Captopril—systemic scleroderma	0.000537	0.0013	CcSEcCtD
Ticagrelor—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000536	0.0013	CcSEcCtD
Ticagrelor—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000535	0.0013	CcSEcCtD
Ticagrelor—Feeling abnormal—Leflunomide—systemic scleroderma	0.000533	0.00129	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000533	0.00129	CcSEcCtD
Ticagrelor—Fatigue—Mycophenolic acid—systemic scleroderma	0.000532	0.00129	CcSEcCtD
Ticagrelor—Nausea—Mometasone—systemic scleroderma	0.000531	0.00129	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000529	0.00128	CcSEcCtD
Ticagrelor—Constipation—Mycophenolic acid—systemic scleroderma	0.000528	0.00128	CcSEcCtD
Ticagrelor—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000524	0.00127	CcSEcCtD
Ticagrelor—Cough—Mycophenolate mofetil—systemic scleroderma	0.000521	0.00126	CcSEcCtD
Ticagrelor—Hypotension—Lisinopril—systemic scleroderma	0.000519	0.00126	CcSEcCtD
Ticagrelor—Dizziness—Captopril—systemic scleroderma	0.000519	0.00126	CcSEcCtD
Ticagrelor—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000515	0.00125	CcSEcCtD
Ticagrelor—Body temperature increased—Leflunomide—systemic scleroderma	0.000511	0.00124	CcSEcCtD
Ticagrelor—Abdominal pain—Leflunomide—systemic scleroderma	0.000511	0.00124	CcSEcCtD
Ticagrelor—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000508	0.00124	CcSEcCtD
Ticagrelor—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000508	0.00123	CcSEcCtD
Ticagrelor—Breast disorder—Methotrexate—systemic scleroderma	0.000507	0.00123	CcSEcCtD
Ticagrelor—Hypersensitivity—Azathioprine—systemic scleroderma	0.000505	0.00123	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000504	0.00123	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000504	0.00123	CcSEcCtD
Ticagrelor—Paraesthesia—Lisinopril—systemic scleroderma	0.000499	0.00121	CcSEcCtD
Ticagrelor—Vomiting—Captopril—systemic scleroderma	0.000499	0.00121	CcSEcCtD
Ticagrelor—Dyspnoea—Lisinopril—systemic scleroderma	0.000495	0.0012	CcSEcCtD
Ticagrelor—Rash—Captopril—systemic scleroderma	0.000495	0.0012	CcSEcCtD
Ticagrelor—Dermatitis—Captopril—systemic scleroderma	0.000494	0.0012	CcSEcCtD
Ticagrelor—Headache—Captopril—systemic scleroderma	0.000492	0.00119	CcSEcCtD
Ticagrelor—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00119	CcSEcCtD
Ticagrelor—Dyspepsia—Lisinopril—systemic scleroderma	0.000489	0.00119	CcSEcCtD
Ticagrelor—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000488	0.00118	CcSEcCtD
Ticagrelor—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000488	0.00118	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00048	0.00117	CcSEcCtD
Ticagrelor—Fatigue—Lisinopril—systemic scleroderma	0.000479	0.00116	CcSEcCtD
Ticagrelor—Shock—Mycophenolate mofetil—systemic scleroderma	0.000479	0.00116	CcSEcCtD
Ticagrelor—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00116	CcSEcCtD
Ticagrelor—Hypersensitivity—Leflunomide—systemic scleroderma	0.000476	0.00116	CcSEcCtD
Ticagrelor—Constipation—Lisinopril—systemic scleroderma	0.000475	0.00115	CcSEcCtD
Ticagrelor—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000473	0.00115	CcSEcCtD
Ticagrelor—Bradycardia—Prednisone—systemic scleroderma	0.000473	0.00115	CcSEcCtD
Ticagrelor—Diarrhoea—Azathioprine—systemic scleroderma	0.000469	0.00114	CcSEcCtD
Ticagrelor—Haemoglobin—Prednisone—systemic scleroderma	0.000467	0.00113	CcSEcCtD
Ticagrelor—Nausea—Captopril—systemic scleroderma	0.000466	0.00113	CcSEcCtD
Ticagrelor—Haemorrhage—Prednisone—systemic scleroderma	0.000465	0.00113	CcSEcCtD
Ticagrelor—Asthenia—Leflunomide—systemic scleroderma	0.000464	0.00113	CcSEcCtD
Ticagrelor—Feeling abnormal—Lisinopril—systemic scleroderma	0.000458	0.00111	CcSEcCtD
Ticagrelor—Pruritus—Leflunomide—systemic scleroderma	0.000458	0.00111	CcSEcCtD
Ticagrelor—Connective tissue disorder—Prednisone—systemic scleroderma	0.000456	0.00111	CcSEcCtD
Ticagrelor—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000455	0.00111	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000454	0.0011	CcSEcCtD
Ticagrelor—Dizziness—Azathioprine—systemic scleroderma	0.000453	0.0011	CcSEcCtD
Ticagrelor—Asthenia—Mycophenolic acid—systemic scleroderma	0.000443	0.00108	CcSEcCtD
Ticagrelor—Diarrhoea—Leflunomide—systemic scleroderma	0.000442	0.00108	CcSEcCtD
Ticagrelor—Abdominal pain—Lisinopril—systemic scleroderma	0.000439	0.00107	CcSEcCtD
Ticagrelor—Body temperature increased—Lisinopril—systemic scleroderma	0.000439	0.00107	CcSEcCtD
Ticagrelor—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000437	0.00106	CcSEcCtD
Ticagrelor—Pruritus—Mycophenolic acid—systemic scleroderma	0.000436	0.00106	CcSEcCtD
Ticagrelor—Vomiting—Azathioprine—systemic scleroderma	0.000435	0.00106	CcSEcCtD
Ticagrelor—Eye disorder—Prednisone—systemic scleroderma	0.000434	0.00105	CcSEcCtD
Ticagrelor—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00105	CcSEcCtD
Ticagrelor—Rash—Azathioprine—systemic scleroderma	0.000432	0.00105	CcSEcCtD
Ticagrelor—Dermatitis—Azathioprine—systemic scleroderma	0.000431	0.00105	CcSEcCtD
Ticagrelor—Headache—Azathioprine—systemic scleroderma	0.000429	0.00104	CcSEcCtD
Ticagrelor—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000429	0.00104	CcSEcCtD
Ticagrelor—Dizziness—Leflunomide—systemic scleroderma	0.000428	0.00104	CcSEcCtD
Ticagrelor—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000422	0.00103	CcSEcCtD
Ticagrelor—Angiopathy—Prednisone—systemic scleroderma	0.000421	0.00102	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00102	CcSEcCtD
Ticagrelor—Immune system disorder—Prednisone—systemic scleroderma	0.00042	0.00102	CcSEcCtD
Ticagrelor—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00101	CcSEcCtD
Ticagrelor—Haematuria—Methotrexate—systemic scleroderma	0.000412	0.001	CcSEcCtD
Ticagrelor—Vomiting—Leflunomide—systemic scleroderma	0.000411	0.000999	CcSEcCtD
Ticagrelor—Hypersensitivity—Lisinopril—systemic scleroderma	0.000409	0.000995	CcSEcCtD
Ticagrelor—Dizziness—Mycophenolic acid—systemic scleroderma	0.000408	0.000991	CcSEcCtD
Ticagrelor—Epistaxis—Methotrexate—systemic scleroderma	0.000408	0.000991	CcSEcCtD
Ticagrelor—Rash—Leflunomide—systemic scleroderma	0.000408	0.000991	CcSEcCtD
Ticagrelor—Dermatitis—Leflunomide—systemic scleroderma	0.000407	0.00099	CcSEcCtD
Ticagrelor—Mental disorder—Prednisone—systemic scleroderma	0.000407	0.000989	CcSEcCtD
Ticagrelor—Nausea—Azathioprine—systemic scleroderma	0.000407	0.000988	CcSEcCtD
Ticagrelor—Headache—Leflunomide—systemic scleroderma	0.000405	0.000984	CcSEcCtD
Ticagrelor—Malnutrition—Prednisone—systemic scleroderma	0.000404	0.000983	CcSEcCtD
Ticagrelor—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000401	0.000975	CcSEcCtD
Ticagrelor—Asthenia—Lisinopril—systemic scleroderma	0.000399	0.000969	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000398	0.000967	CcSEcCtD
Ticagrelor—Pruritus—Lisinopril—systemic scleroderma	0.000393	0.000955	CcSEcCtD
Ticagrelor—Vomiting—Mycophenolic acid—systemic scleroderma	0.000392	0.000953	CcSEcCtD
Ticagrelor—Haemoglobin—Methotrexate—systemic scleroderma	0.00039	0.000948	CcSEcCtD
Ticagrelor—Rash—Mycophenolic acid—systemic scleroderma	0.000389	0.000945	CcSEcCtD
Ticagrelor—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000389	0.000944	CcSEcCtD
Ticagrelor—Haemorrhage—Methotrexate—systemic scleroderma	0.000388	0.000943	CcSEcCtD
Ticagrelor—Headache—Mycophenolic acid—systemic scleroderma	0.000386	0.000939	CcSEcCtD
Ticagrelor—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000935	CcSEcCtD
Ticagrelor—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000385	0.000935	CcSEcCtD
Ticagrelor—Nausea—Leflunomide—systemic scleroderma	0.000384	0.000933	CcSEcCtD
Ticagrelor—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000383	0.000932	CcSEcCtD
Ticagrelor—Urethral disorder—Methotrexate—systemic scleroderma	0.000381	0.000925	CcSEcCtD
Ticagrelor—Diarrhoea—Lisinopril—systemic scleroderma	0.00038	0.000924	CcSEcCtD
Ticagrelor—Angioedema—Prednisone—systemic scleroderma	0.00037	0.000898	CcSEcCtD
Ticagrelor—Dizziness—Lisinopril—systemic scleroderma	0.000367	0.000893	CcSEcCtD
Ticagrelor—Nausea—Mycophenolic acid—systemic scleroderma	0.000366	0.00089	CcSEcCtD
Ticagrelor—Vertigo—Prednisone—systemic scleroderma	0.000363	0.000883	CcSEcCtD
Ticagrelor—Eye disorder—Methotrexate—systemic scleroderma	0.000363	0.000882	CcSEcCtD
Ticagrelor—Syncope—Prednisone—systemic scleroderma	0.000363	0.000881	CcSEcCtD
Ticagrelor—Cardiac disorder—Methotrexate—systemic scleroderma	0.00036	0.000875	CcSEcCtD
Ticagrelor—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000872	CcSEcCtD
Ticagrelor—Loss of consciousness—Prednisone—systemic scleroderma	0.000355	0.000864	CcSEcCtD
Ticagrelor—Vomiting—Lisinopril—systemic scleroderma	0.000353	0.000858	CcSEcCtD
Ticagrelor—Angiopathy—Methotrexate—systemic scleroderma	0.000352	0.000856	CcSEcCtD
Ticagrelor—Immune system disorder—Methotrexate—systemic scleroderma	0.000351	0.000852	CcSEcCtD
Ticagrelor—Rash—Lisinopril—systemic scleroderma	0.00035	0.000851	CcSEcCtD
Ticagrelor—Dermatitis—Lisinopril—systemic scleroderma	0.00035	0.000851	CcSEcCtD
Ticagrelor—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00035	0.00085	CcSEcCtD
Ticagrelor—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000849	CcSEcCtD
Ticagrelor—Hypertension—Prednisone—systemic scleroderma	0.000349	0.000848	CcSEcCtD
Ticagrelor—Headache—Lisinopril—systemic scleroderma	0.000348	0.000846	CcSEcCtD
Ticagrelor—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000837	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000342	0.000831	CcSEcCtD
Ticagrelor—Mental disorder—Methotrexate—systemic scleroderma	0.00034	0.000826	CcSEcCtD
Ticagrelor—Malnutrition—Methotrexate—systemic scleroderma	0.000338	0.000821	CcSEcCtD
Ticagrelor—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000333	0.000809	CcSEcCtD
Ticagrelor—Nausea—Lisinopril—systemic scleroderma	0.00033	0.000802	CcSEcCtD
Ticagrelor—Back pain—Methotrexate—systemic scleroderma	0.000327	0.000794	CcSEcCtD
Ticagrelor—Shock—Prednisone—systemic scleroderma	0.000325	0.000789	CcSEcCtD
Ticagrelor—Nervous system disorder—Prednisone—systemic scleroderma	0.000324	0.000786	CcSEcCtD
Ticagrelor—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000782	CcSEcCtD
Ticagrelor—Skin disorder—Prednisone—systemic scleroderma	0.000321	0.000779	CcSEcCtD
Ticagrelor—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00031	0.000752	CcSEcCtD
Ticagrelor—Rash—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000746	CcSEcCtD
Ticagrelor—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000745	CcSEcCtD
Ticagrelor—Headache—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000741	CcSEcCtD
Ticagrelor—Vertigo—Methotrexate—systemic scleroderma	0.000304	0.000738	CcSEcCtD
Ticagrelor—Paraesthesia—Prednisone—systemic scleroderma	0.000296	0.00072	CcSEcCtD
Ticagrelor—Cough—Methotrexate—systemic scleroderma	0.000295	0.000717	CcSEcCtD
Ticagrelor—Dyspepsia—Prednisone—systemic scleroderma	0.000291	0.000706	CcSEcCtD
Ticagrelor—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000703	CcSEcCtD
Ticagrelor—Chest pain—Methotrexate—systemic scleroderma	0.000288	0.000699	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000286	0.000694	CcSEcCtD
Ticagrelor—Fatigue—Prednisone—systemic scleroderma	0.000285	0.000691	CcSEcCtD
Ticagrelor—Constipation—Prednisone—systemic scleroderma	0.000282	0.000686	CcSEcCtD
Ticagrelor—Confusional state—Methotrexate—systemic scleroderma	0.000278	0.000676	CcSEcCtD
Ticagrelor—Feeling abnormal—Prednisone—systemic scleroderma	0.000272	0.000661	CcSEcCtD
Ticagrelor—Nervous system disorder—Methotrexate—systemic scleroderma	0.00027	0.000657	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00027	0.000656	CcSEcCtD
Ticagrelor—Skin disorder—Methotrexate—systemic scleroderma	0.000268	0.000651	CcSEcCtD
Ticagrelor—Abdominal pain—Prednisone—systemic scleroderma	0.000261	0.000634	CcSEcCtD
Ticagrelor—Body temperature increased—Prednisone—systemic scleroderma	0.000261	0.000634	CcSEcCtD
Ticagrelor—Hypotension—Methotrexate—systemic scleroderma	0.000258	0.000626	CcSEcCtD
Ticagrelor—Paraesthesia—Methotrexate—systemic scleroderma	0.000248	0.000602	CcSEcCtD
Ticagrelor—Dyspnoea—Methotrexate—systemic scleroderma	0.000246	0.000597	CcSEcCtD
Ticagrelor—Hypersensitivity—Prednisone—systemic scleroderma	0.000243	0.000591	CcSEcCtD
Ticagrelor—Dyspepsia—Methotrexate—systemic scleroderma	0.000243	0.00059	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000238	0.000579	CcSEcCtD
Ticagrelor—Fatigue—Methotrexate—systemic scleroderma	0.000238	0.000578	CcSEcCtD
Ticagrelor—Asthenia—Prednisone—systemic scleroderma	0.000237	0.000575	CcSEcCtD
Ticagrelor—Pruritus—Prednisone—systemic scleroderma	0.000233	0.000567	CcSEcCtD
Ticagrelor—Feeling abnormal—Methotrexate—systemic scleroderma	0.000227	0.000552	CcSEcCtD
Ticagrelor—Diarrhoea—Prednisone—systemic scleroderma	0.000226	0.000549	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000226	0.000548	CcSEcCtD
Ticagrelor—Dizziness—Prednisone—systemic scleroderma	0.000218	0.00053	CcSEcCtD
Ticagrelor—Abdominal pain—Methotrexate—systemic scleroderma	0.000218	0.00053	CcSEcCtD
Ticagrelor—Body temperature increased—Methotrexate—systemic scleroderma	0.000218	0.00053	CcSEcCtD
Ticagrelor—Vomiting—Prednisone—systemic scleroderma	0.00021	0.00051	CcSEcCtD
Ticagrelor—Rash—Prednisone—systemic scleroderma	0.000208	0.000506	CcSEcCtD
Ticagrelor—Dermatitis—Prednisone—systemic scleroderma	0.000208	0.000505	CcSEcCtD
Ticagrelor—Headache—Prednisone—systemic scleroderma	0.000207	0.000502	CcSEcCtD
Ticagrelor—Hypersensitivity—Methotrexate—systemic scleroderma	0.000203	0.000494	CcSEcCtD
Ticagrelor—Asthenia—Methotrexate—systemic scleroderma	0.000198	0.000481	CcSEcCtD
Ticagrelor—Nausea—Prednisone—systemic scleroderma	0.000196	0.000476	CcSEcCtD
Ticagrelor—Pruritus—Methotrexate—systemic scleroderma	0.000195	0.000474	CcSEcCtD
Ticagrelor—Diarrhoea—Methotrexate—systemic scleroderma	0.000189	0.000459	CcSEcCtD
Ticagrelor—Dizziness—Methotrexate—systemic scleroderma	0.000182	0.000443	CcSEcCtD
Ticagrelor—Vomiting—Methotrexate—systemic scleroderma	0.000175	0.000426	CcSEcCtD
Ticagrelor—Rash—Methotrexate—systemic scleroderma	0.000174	0.000423	CcSEcCtD
Ticagrelor—Dermatitis—Methotrexate—systemic scleroderma	0.000174	0.000422	CcSEcCtD
Ticagrelor—Headache—Methotrexate—systemic scleroderma	0.000173	0.00042	CcSEcCtD
Ticagrelor—Nausea—Methotrexate—systemic scleroderma	0.000164	0.000398	CcSEcCtD
